Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.

Anthwal A, Rajesh UC, Rawat MS, Kushwaha B, Maikhuri JP, Sharma VL, Gupta G, Rawat DS.

Eur J Med Chem. 2014 May 22;79:89-94. doi: 10.1016/j.ejmech.2014.03.076. Epub 2014 Mar 28.

PMID:
24727243
2.
3.

Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.

Seña AC, Bachmann LH, Hobbs MM.

Expert Rev Anti Infect Ther. 2014 Jun;12(6):673-85. doi: 10.1586/14787210.2014.887440. Epub 2014 Feb 20. Review.

PMID:
24555561
4.

Efficacy of two plant extracts against vaginal trichomoniasis.

El-Sherbini GT, El Gozamy BR, Abdel-Hady NM, Morsy TA.

J Egypt Soc Parasitol. 2009 Apr;39(1):47-58.

PMID:
19530609
5.

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE.

Clin Microbiol Rev. 2004 Oct;17(4):783-93, table of contents. Review.

6.

New chemotherapeutic nitroheterocycles active against 5-nitroimidazole-resistant strains of trichomonads.

Meingassner JG, Nesvadba H, Mieth H.

Arzneimittelforschung. 1981;31(1):6-8.

PMID:
6971111
7.
8.

Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis.

Chen MY, Smith NA, Fox EF, Bingham JS, Barlow D.

Int J STD AIDS. 1999 Apr;10(4):277-80. No abstract available.

PMID:
12035784
9.

A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.

Ray DK, Tendulkar JS, Shrivastava VB, Datta AK, Nagarajan K.

J Antimicrob Chemother. 1984 Oct;14(4):423-6.

PMID:
6334072
10.

In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.

Adagu IS, Nolder D, Warhurst DC, Rossignol JF.

J Antimicrob Chemother. 2002 Jan;49(1):103-11.

PMID:
11751773
11.

In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.

Blaha C, Duchêne M, Aspöck H, Walochnik J.

J Antimicrob Chemother. 2006 Feb;57(2):273-8. Epub 2005 Dec 12.

PMID:
16344287
12.

In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.

Narcisi EM, Secor WE.

Antimicrob Agents Chemother. 1996 May;40(5):1121-5.

13.

Management of metronidazole-resistant Trichomonas vaginalis--a new approach.

Mammen-Tobin A, Wilson JD.

Int J STD AIDS. 2005 Jul;16(7):488-90.

PMID:
16004628
15.

Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.

Rasoloson D, Tomková E, Cammack R, Kulda J, Tachezy J.

Parasitology. 2001 Jul;123(Pt 1):45-56.

PMID:
11467782
16.

[In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].

Aksoy Gökmen A, Girginkardeşler N, Kilimcioğlu AA, Şirin MC, Özbilgin A.

Mikrobiyol Bul. 2016 Jan;50(1):133-9. Turkish.

17.

Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.

Dunne RL, Dunn LA, Upcroft P, O'Donoghue PJ, Upcroft JA.

Cell Res. 2003 Aug;13(4):239-49. Review.

18.

The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.

Rocha DA, de Andrade Rosa I, Urbina JA, de Souza W, Benchimol M.

Parasitol Res. 2014 Jun;113(6):2185-97. doi: 10.1007/s00436-014-3871-3. Epub 2014 Apr 22.

PMID:
24752367
19.

In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.

Müller M, Lossick JG, Gorrell TE.

Sex Transm Dis. 1988 Jan-Mar;15(1):17-24.

PMID:
3258675
20.

Treatment of metronidazole-resistant Trichomonas vaginalis.

Goldman LM, Upcroft JA, Workowski K, Rapkin A.

Sex Health. 2009 Dec;6(4):345-7. doi: 10.1071/SH09064.

PMID:
19917205

Supplemental Content

Support Center